OPYL LTD

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2022, OPYL LTD has already paid €1.00 in dividends. The last payout was in September 2022.

Financials

In the last year, OPYL LTD had revenue of €247.2k and net profit of -€1.95m

(EUR)	2024	YoY
Revenue	247.2k	34.45%
Gross profit	-869.73k	36.75%
Net profit	-1.95m	84.71%
EBITDA	-1.67m	60.70%

Fundamentals

Metric	Value
Market capitalization	€3.33m
Number of shares	245.77m
52-week high/low	€0.0221 - €0.00861
Dividends	No
Beta	1.06
P/E ratio	-1.93
PEG ratio	0.05
P/B ratio	0.20
P/S ratio	454.00

Company profile

Opyl Limited develops digital tools that improves healthcare experience for patients in Australia. It also offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials; and social media marketing agency services, such as client and account management services for pharmaceutical, medtech, and biotech industries. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in St Kilda, Australia.